Group | Gender, Age | Cirrhosis | HCV Treatment Duration | eGFR at baseline (ml/min/m2) | eGFR at W4 (ml/min/m2) | eGFR at EOT (ml/min/m2) | eGFR at SVR12 (ml/min/m2) | |
---|---|---|---|---|---|---|---|---|
1 | Non-TDF | Male, 66 yo | Yes | 12w | 59 | 45.3 | 56.9 | 63.9 |
2 | Non-TDF | Male, 48 yo | Yes | 24w | 60 | 62.8 | 54.3 | 57.5 |
3 | Non-TDF | Male, 49 yo | Yes | 24w | 65.9 | 57.1 | 37.8 | 32 |
4 | Non-TDF | Male, 55 yo | Yes | 12w | 67.7 | 62 | 59.8 | 57.7 |
5 | Non-boosted TDF | Male, 55 yo | Yes | 24w | 72.8 | 57.7 | 60.9 | 71.2 |
6 | TDF+ Boosted PI | Male, 45 yo | Yes | 24w | 80.6 | 64.1 | 57.7 | 83.4 |